GHK-Cu Peptide Injection Dosage Guide: Purity, Specification & Manufacturing Standards for Labs

Core Molecular Specs & Technical Index

GHK-Cu, or copper tripeptide-1, is a naturally occurring copper complex renowned for its role in cellular signaling and tissue remodeling. For B2B buyers—including cosmetic formulation labs, research institutions, and raw material wholesalers—understanding the precise technical specifications is the first step in evaluating any ghk-cu peptide injection dosage supply. The molecule consists of a glycyl-histidyl-lysine tripeptide chelated with a copper ion, giving it a characteristic blue color and a molecular weight of approximately 340.8 g/mol.

High-purity GHK-Cu for injection must meet rigorous standards to ensure stability and efficacy in downstream applications. The following technical indices are critical for any laboratory or manufacturing facility sourcing this peptide:

• Purity (HPLC): Minimum 98% by high-performance liquid chromatography, with top-tier suppliers offering 99%+ for research-grade material.
• Copper Content: Typically 1.8%–2.2% by weight, verified by atomic absorption spectroscopy (AAS) or inductively coupled plasma mass spectrometry (ICP-MS).
• Solubility: Freely soluble in water (≥50 mg/mL) and sterile saline, forming a clear blue solution without visible particulates.
• Storage Conditions: Lyophilized powder must be stored at -20°C in airtight, light-protected vials; reconstituted solutions are stable for 7–10 days at 2–8°C.
• Endotoxin Levels: Less than 1.0 EU/mg for injectable-grade material, ensuring compliance with pharmacopeial standards for parenteral use.

Industry data from the 2023 Peptide Therapeutics Report indicates that over 65% of laboratory-grade GHK-Cu batches fail initial quality checks due to substandard purity or incorrect copper chelation ratios. This underscores the importance of sourcing from manufacturers with validated analytical methods and batch-to-batch consistency.

Manufacturing & Quality Control

The production of high-grade GHK-Cu for injection involves a multi-step process that begins with solid-phase peptide synthesis (SPPS). This method allows for precise control over the amino acid sequence and minimizes racemization. After synthesis, the peptide is cleaved from the resin and purified using preparative reverse-phase HPLC, which separates the target molecule from truncated sequences and other impurities.

Copper chelation is performed under controlled pH and temperature conditions to ensure complete and stable binding. The final lyophilization step removes residual solvents and water, yielding a stable powder suitable for long-term storage. Every batch must undergo a comprehensive suite of quality control tests before release:

• HPLC Purity Analysis: Confirms the main peak area percentage and identifies any related substances.
• Mass Spectrometry (MS): Validates molecular weight and confirms the correct copper-peptide complex.
• Heavy Metal Testing: Ensures levels of lead, arsenic, cadmium, and mercury are below ICH Q3D limits.
• Residual Solvent Analysis: GC-MS verification that acetonitrile and TFA levels are within safe thresholds.
• Certificate of Analysis (CoA): Provided with each batch, detailing all test results and storage recommendations.

Third-party testing by an ISO 17025-accredited laboratory adds an extra layer of assurance for B2B buyers. Reputable suppliers will share these reports upon request, allowing you to verify the ghk-cu peptide injection dosage specifications before committing to a bulk order.

Commercial Application Scenarios

GHK-Cu is a versatile raw material with established demand across multiple B2B sectors. Understanding these application scenarios helps buyers align their purchasing criteria with end-use requirements.

Cosmetic Formulation: In the personal care industry, GHK-Cu is incorporated into serums, creams, and masks at concentrations ranging from 0.1% to 1.0%. Formulators require a water-soluble, highly pure peptide that dissolves completely without aggregation. The ghk-cu peptide injection dosage grade is often preferred because its low endotoxin profile and high purity translate to better stability and fewer formulation issues.

Lab Research: Research institutions studying wound healing, angiogenesis, or cellular senescence use GHK-Cu in cell culture models. Typical working concentrations are 1–100 µM, requiring precise reconstitution and dilution. Labs demand consistent batch quality to ensure reproducible results across experiments.

Bulk Wholesale: Distributors and contract manufacturers purchase GHK-Cu in multi-gram to kilogram quantities. They prioritize suppliers who can provide competitive pricing without compromising on purity, along with comprehensive documentation for regulatory filings. The ability to supply a consistent ghk-cu peptide injection dosage standard is a key differentiator in this segment.

ghk-cu peptide injection dosage VS Ordinary Low-Grade Peptides

Bulk Purchase Selection Guide

When sourcing GHK-Cu for injection in bulk, B2B buyers must navigate several common pitfalls to ensure they receive a product that meets their specifications. The following checklist will help you evaluate suppliers and avoid costly mistakes.

Common Pitfalls:

• Misleading Purity Claims: Some suppliers report purity based on UV detection only, which can overestimate actual content. Always request HPLC chromatograms with peak integration data.
• Incomplete Documentation: Without a full Certificate of Analysis and third-party test reports, you cannot verify the ghk-cu peptide injection dosage specifications. Avoid suppliers who are unwilling to share these documents.
• Inconsistent Batch Quality: Low-cost suppliers may mix batches from different synthesis runs, leading to variability in copper content and solubility. Request batch-specific CoAs for every order.

Selection Standards:

• Verify that the supplier uses SPPS with Fmoc chemistry and preparative HPLC purification.
• Confirm that endotoxin testing is performed using the LAL method with a validated protocol.
• Ask about the supplier’s quality management system—ISO 9001 certification is a strong indicator of reliability.
• Request a small sample (100–500 mg) for in-house testing before placing a large order.

Buyer Checklist:

• ☐ HPLC purity ≥99% with full chromatogram
• ☐ Endotoxin level <1.0 EU/mg
• ☐ Copper content within 1.8–2.2%
• ☐ Third-party test report from an accredited lab
• ☐ Clear solubility at 50 mg/mL in water
• ☐ Batch-specific CoA and MSDS provided

Core Product Advantages

Our GHK-Cu injection-grade peptide offers distinct advantages that make it the preferred choice for laboratories and manufacturers worldwide. These benefits are rooted in our commitment to quality control and technical support.

Purity & Stability: With a guaranteed purity of ≥99% by HPLC and endotoxin levels below 0.5 EU/mg, our product meets the most stringent requirements for injectable and research applications. The lyophilized powder remains stable for over 24 months when stored at -20°C, and reconstituted solutions maintain full activity for 10 days under refrigeration.

Cost Performance: By optimizing our synthesis and purification processes, we offer competitive pricing without sacrificing quality. Our bulk pricing structure rewards larger orders, making us a cost-effective partner for ongoing projects. The consistent ghk-cu peptide injection dosage specifications reduce the need for re-testing and reformulation, saving you time and money.

Technical Support: Our team of peptide chemists and application specialists is available to assist with reconstitution protocols, formulation advice, and troubleshooting. We provide detailed technical documentation, including stability data and compatibility studies, to support your research or product development.

Frequently Asked Questions

Q: What is the standard ghk-cu peptide injection dosage for laboratory research?
A: In cell culture studies, GHK-Cu is typically used at concentrations between 1 µM and 100 µM, depending on the experimental model. For in vivo research, dosages range from 0.5 mg/kg to 5 mg/kg, administered via intraperitoneal or subcutaneous injection. Always reconstitute the lyophilized powder in sterile water or saline to achieve the desired concentration, and filter-sterilize the solution before use.

Q: How do I verify the purity of GHK-Cu from a new supplier?
A: Request a Certificate of Analysis that includes an HPLC chromatogram with peak area percentages, mass spectrometry confirmation, and endotoxin test results. For added assurance, send a sample to an independent ISO 17025-accredited laboratory for third-party analysis. Compare the copper content and solubility data against the specifications provided by the supplier.

Q: Can GHK-Cu injection-grade peptide be used in cosmetic formulations?
A: Yes, injection-grade GHK-Cu is suitable for cosmetic formulations due to its high purity and low endotoxin levels. However, formulators must ensure that the final product complies with local cosmetic regulations. The peptide should be incorporated at concentrations of 0.1% to 1.0% in water-based systems, and the pH should be adjusted to 5.5–6.5 for optimal stability and skin compatibility.